Drugs / CS1 Targeted CAR T-cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04541368 | Dec 2020 → Dec 2023 overdue | — | Zhejiang University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CS1 Targeted CAR T-cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04541368 ↗ |
| Modality | Cell therapy | “CS1-targeted CAR-T Cells Therapy” NCT04541368 ↗ |
| Route | Intravenous | “Each subject receive CS1 Targeted CAR T-cells by intravenous infusion” NCT04541368 ↗ |